查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830800

2025年介入性肿瘤学全球市场报告

Interventional Oncology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，介入性肿瘤学市场规模强劲成长，从2024年的24.9亿美元增加至2025年的27.2亿美元，复合年增长率达9.2%。这段时期的成长可归因于全球癌症发生率的上升、微创手术的普及、新兴国家医疗保健支出的增加、对影像引导手术的需求不断增长，以及人们对介入肿瘤学益处的认识不断提高。

预计未来几年介入肿瘤学市场将强劲成长，到2029年将达到38.2亿美元，复合年增长率为8.8%。预测期内的成长归因于门诊肿瘤治疗需求的不断增长、联合治疗与免疫肿瘤学应用的不断增加、影像引导治疗临床试验的扩展、新兴市场介入肿瘤学可及性的提升，以及精准医疗在治疗计划中日益重要的作用。预测期内的主要趋势包括影像导引消融技术的进步、人工智慧诊断工具的发展、标靶给药系统的创新、微创治疗设备的进步以及个人化肿瘤治疗方案的出现。

介入性肿瘤学是一门专注于利用微创影像引导技术诊断和治疗癌症的医学专业。其主要目标是提供有效的癌症治疗，相比传统手术方法，其恢復时间更短，副作用更少。

介入性肿瘤学设备的主要类型包括放射治疗设备、消融设备和栓塞设备。放射治疗设备是专门设计的机器，用于将精确剂量的电离辐射传送到体内的目标区域，目的是摧毁或损伤异常细胞，同时最大限度地减少对周围健康组织的伤害。这些设备采用超音波、电脑断层扫描 (CT) 引导和磁振造影(MRI) 引导等技术。使用这些设备执行的程序包括肿瘤切除、肿瘤切片检查、血管介入和安宁疗护。这些治疗适用于多种癌症，包括肝癌、肺癌、肾癌、胰腺癌和前列腺癌，并服务于各种最终用户，包括医院、门诊手术中心、专科诊所以及研究和学术机构。

2025年春季美国突然提高关税以及由此引发的贸易摩擦严重影响了医疗保健产业，尤其是关键医疗设备、诊断设备和药品的供应。医院和医疗机构面临进口手术器械、影像设备以及注射器和导管等消耗品成本上涨的问题。这些成本上涨给医疗保健预算带来了巨大压力，导致一些医疗机构推迟设备升级或将成本转嫁给患者。此外，原料和零件的关税阻碍了基本药品和医疗设备的生产，造成供应链瓶颈。作为应对措施，该行业正在使其筹资策略多样化，尽可能促进本地生产，并倡导紧急医疗产品免关税。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供介入肿瘤学市场统计数据，例如全球市场规模、区域份额、介入肿瘤学市场份额的竞争对手、详细的介入肿瘤学细分市场、市场趋势和商业机会，以及您在介入肿瘤学行业取得成功所需的数据。本介入性肿瘤学市场研究报告对该行业的现状和未来趋势进行了详细分析，以完整的观点为您提供所需的所有资讯。

预计未来几年癌症盛行率的上升将推动介入肿瘤学市场的成长。癌症盛行率是指在总合时间内新诊断出癌症的人数加上先前诊断出的人数。癌症患者数量的增加主要是由于生活方式相关的风险因素，例如不良饮食、吸烟、饮酒和接触环境污染物。介入性肿瘤学透过提供直接针对肿瘤的微创标靶治疗来支持癌症治疗。与传统治疗方法相比，这些方法透过减少对健康组织的伤害和加速復原来改善患者的预后。例如，根据澳洲政府机构澳洲健康与福利研究所的数据，截至 2024 年 7 月，2022 年澳洲诊断出的癌症患者为 160,570 人，比 2021 年的 156,781 人增加了 3,789 人。因此，癌症盛行率的上升正在推动介入肿瘤学市场的扩张。

介入肿瘤学市场的公司正在开发先进技术，例如基于微导管的栓塞系统，以实现高度精确和有针对性的癌症治疗，同时最大限度地减少对周围健康组织的损害。以微导管为基础的栓塞系统使用小型柔性导管将栓塞剂直接输送到血管中，阻断或减少血流。它们通常用于医疗设备肿瘤、血管畸形和出血。例如，2025 年 3 月，日本医疗设备製造商Terumo Corporation推出了 Occlusafe 球囊闭塞导管，作为肝癌（特别是肝细胞癌 (HCC)）球囊 TACE (B-TACE) 治疗的一部分。这种专用微导管利用压力梯度效应来改变血流方向并进入微循环，从而能够将更高浓度的治疗剂输送到肿瘤部位，同时最大限度地减少脱靶栓塞。这种有针对性的方法旨在透过提高药物输送的精确度和改善手术过程中的可视性来改善棘手肝癌病例的临床结果。

2022年8月，美国医疗设备製造商波士顿科学公司（Boston Scientific）收购了Obsidio，具体金额未揭露。透过此次收购，波士顿科学公司希望透过整合独特的栓塞技术来扩大其介入性肿瘤学和栓塞治疗产品组合，从而提高手术效率并实现个人化治疗。 Obsidio是一家总部位于美国的公司，专注于创新的介入性肿瘤学解决方案。

介入性肿瘤学市场包括提供影像导引肿瘤切除、切片检查和诊断影像、疼痛缓解程序以及热消融计划和追踪等服务的营业单位所获得的收益。市场价值还包括服务提供者销售的或包含在其服务产品中的相关产品的价值。介入肿瘤学市场还包括影像引导导航系统、导管和导管导引线、放射输送系统以及切片穿刺针和系统的销售。这代表产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品的价值。该市场中的产品价值还包括产品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球介入性肿瘤学：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球介入性肿瘤学市场：成长率分析
  • 全球介入性肿瘤学市场表现：规模与成长，2019-2024
  • 全球介入性肿瘤学市场预测：2024-2029年及2034年规模与成长
  • 全球介入性肿瘤学：总目标市场（TAM）

第六章 市场细分

  • 全球介入性肿瘤学市场：依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 放射治疗设备
  • 消融设备
  • 栓塞装置
  • 全球介入性肿瘤学市场（按技术类型划分）：实际值和预测值，2019-2024 年、2024-2029 年、2034 年
  • 超音波
  • CT引导下
  • 磁共振感应
  • 全球介入性肿瘤学市场（按程序、实际情况和预测），2019-2024 年、2024-2029 年、2034 年
  • 肿瘤消融
  • 肿瘤切片检查
  • 血管介入
  • 安宁疗护
  • 全球介入性肿瘤学市场的应用、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 肝癌
  • 肺癌
  • 肾癌
  • 胰臟癌
  • 摄护腺癌
  • 全球介入性肿瘤学市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心
  • 专科诊所
  • 研究和学术机构
  • 全球介入性肿瘤学市场：放射治疗设备细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 线性加速器
  • 质子治疗系统
  • 近距离放射治疗装置
  • 全球介入性肿瘤学市场：按消融设备类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 射频消融术装置
  • 微波消融装置
  • 冷冻消融装置
  • 不可逆电穿孔系统
  • 全球介入性肿瘤学市场：按栓塞装置细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 微球
  • 线圈栓塞装置
  • 液态栓塞剂
  • 栓塞保护装置

第七章 区域和国家分析

  • 全球介入性肿瘤学市场：区域表现与预测，2019-2024 年、2024-2029 年、2034 年
  • 全球介入性肿瘤学市场：各国表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 介入性肿瘤学市场：竞争格局
  • 介入性肿瘤学市场：公司简介
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Terumo Corporation
  • Hologic Inc.
  • Teleflex Incorporated
  • Lantheus Holdings Inc.
  • Penumbra Inc.
  • Merit Medical Systems Inc.
  • Guerbet SA
  • Asahi Intecc Co. Ltd.
  • AngioDynamics Inc.
  • Sirtex Medical Limited.
  • Delcath Systems Inc.
  • ABK Biomedical Inc.
  • Profound Medical Inc.
  • IceCure Medical Ltd.
  • Minimax Medical Holding Group

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年介入肿瘤学市场：提供新机会的国家
  • 2029年介入肿瘤学市场：细分领域带来新机会
  • 2029年介入肿瘤学市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r37789

Interventional oncology is a medical specialty that focuses on minimally invasive, image-guided procedures for the diagnosis and treatment of cancer. Its primary goal is to provide effective cancer therapies with shorter recovery times and fewer side effects compared to traditional surgical approaches.

The primary types of interventional oncology include radiation therapy devices, ablation devices, and embolization devices. Radiation therapy devices are specialized equipment designed to deliver precise doses of ionizing radiation to targeted areas in the body, aiming to destroy or damage abnormal cells while minimizing harm to surrounding healthy tissue. These devices employ technologies such as ultrasound, computed tomography (CT) guidance, and magnetic resonance imaging (MRI) guidance. Procedures performed using these devices include tumor ablation, tumor biopsy, vascular interventions, and palliative care. These treatments are applied to various cancers, including liver, lung, kidney, pancreatic, and prostate cancers, and serve a range of end-users such as hospitals, ambulatory surgical centers, specialty clinics, and research and academic institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The interventional oncology market research report is one of a series of new reports from The Business Research Company that provides interventional oncology market statistics, including interventional oncology industry global market size, regional shares, competitors with an interventional oncology market share, detailed interventional oncology market segments, market trends and opportunities, and any further data you may need to thrive in the interventional oncology industry. This interventional oncology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The interventional oncology market size has grown strongly in recent years. It will grow from $2.49 billion in 2024 to $2.72 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth during the historic period can be attributed to the rising incidence of cancer globally, increased adoption of minimally invasive procedures, growing healthcare expenditure in emerging economies, higher demand for image-guided therapies, and heightened awareness of the benefits of interventional oncology.

The interventional oncology market size is expected to see strong growth in the next few years. It will grow to $3.82 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth during the forecast period can be attributed to the rising demand for outpatient oncology procedures, increased use of combination therapies with immuno-oncology, expanding clinical trials for image-guided therapies, greater access to interventional oncology in emerging markets, and the growing role of precision medicine in treatment planning. Major trends expected in the forecast period include advancements in image-guided ablation technologies, development of AI-powered diagnostic tools, innovations in targeted drug-delivery systems, progress in minimally invasive treatment devices, and the emergence of personalized oncology treatment solutions.

The rising prevalence of cancer is expected to drive growth in the interventional oncology market in the coming years. Cancer prevalence refers to the total number of individuals, both newly and previously diagnosed, who are living with a history of cancer at a given point in time. The increase in cancer cases is largely attributed to lifestyle-related risk factors such as poor diet, smoking, alcohol consumption, and exposure to environmental pollutants, which elevate the likelihood of developing various cancers. Interventional oncology supports cancer treatment by offering minimally invasive, targeted therapies that directly focus on tumors. These approaches enhance patient outcomes by reducing harm to healthy tissue and providing faster recovery compared to conventional treatments. For example, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, 160,570 cancer cases were diagnosed in Australia in 2022, representing an increase of 3,789 cases from 156,781 in 2021. Therefore, the growing prevalence of cancer is propelling the expansion of the interventional oncology market.

Companies in the interventional oncology market are developing advanced technologies, such as microcatheter-based embolization systems, to deliver highly precise, targeted cancer therapy while minimizing damage to surrounding healthy tissue. Microcatheter-based embolization systems are medical devices that use small, flexible catheters to deliver embolic agents directly into blood vessels to block or reduce blood flow, typically for the treatment of tumors, vascular malformations, or bleeding. For instance, in March 2025, Terumo Corporation, a Japan-based medical device company, introduced the Occlusafe balloon occlusion catheter as part of its Balloon-TACE (B-TACE) therapy for liver cancer, particularly hepatocellular carcinoma (HCC). This specialized microcatheter utilizes the pressure gradient effect to redirect blood flow and access the microcirculation, allowing higher concentrations of therapeutic agents at the tumor site while minimizing off-target embolization. This targeted method aims to improve clinical outcomes in challenging liver cancer cases by enhancing drug delivery accuracy and providing better visualization during procedures.

In August 2022, Boston Scientific Corporation, a US-based medical device company, acquired Obsidio Inc. for an undisclosed sum. Through this acquisition, Boston Scientific seeks to expand its interventional oncology and embolization portfolio by integrating a distinctive embolic technology that enhances procedural efficiency and enables personalized therapy for patients. Obsidio Inc. is a US-based company specializing in innovative interventional oncology solutions.

Major players in the interventional oncology market are Johnson & Johnson, Siemens Healthineers AG, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Hologic Inc., Teleflex Incorporated, Lantheus Holdings Inc., Penumbra Inc., Merit Medical Systems Inc., Guerbet S.A, Asahi Intecc Co. Ltd., AngioDynamics Inc., Sirtex Medical Limited., Delcath Systems Inc., ABK Biomedical Inc., Profound Medical Inc., IceCure Medical Ltd., Minimax Medical Holding Group.

North America was the largest region in the interventional oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interventional oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the interventional oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The interventional oncology market consists of revenues earned by entities by providing services such as image-guided tumor ablation, biopsy and diagnostic imaging, pain palliation procedures, and thermal ablation planning and follow-up. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional oncology market also includes sales of image-guided navigation systems, catheters and guidewires, radiation delivery systems, and biopsy needles and systems. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Oncology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional oncology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional oncology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interventional oncology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Radiation Therapy Devices; Ablation Devices; Embolization Devices
  • 2) By Technology Type: Ultrasound; Computed Tomography Guided; Magnetic Resonance-Guided
  • 3) By Procedure: Tumor Ablation; Tumor Biopsy; Vascular Interventions; Palliative Care
  • 4) By Application Areas: Liver Cancer; Lung Cancer; Kidney Cancer; Pancreatic Cancer; Prostate Cancer
  • 5) By End-Users: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Research And Academic Institutions
  • Subsegments:
  • 1) By Radiation Therapy Devices: Linear Accelerators; Proton Therapy Systems; Brachytherapy Devices
  • 2) By Ablation Devices: Radiofrequency Ablation Devices; Microwave Ablation Devices; Cryoablation Devices; Irreversible Electroporation Systems
  • 3) By Embolization Devices: Microspheres; Coil Embolization Devices; Liquid Embolic Agents; Embolic Protection Devices
  • Companies Mentioned: Johnson & Johnson; Siemens Healthineers AG; Stryker Corporation; GE HealthCare Technologies Inc.; Boston Scientific Corporation; Terumo Corporation; Hologic Inc.; Teleflex Incorporated; Lantheus Holdings Inc.; Penumbra Inc.; Merit Medical Systems Inc.; Guerbet S.A; Asahi Intecc Co. Ltd.; AngioDynamics Inc.; Sirtex Medical Limited.; Delcath Systems Inc.; ABK Biomedical Inc.; Profound Medical Inc.; IceCure Medical Ltd.; Minimax Medical Holding Group
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Interventional Oncology Market Characteristics

3. Interventional Oncology Market Trends And Strategies

4. Interventional Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Interventional Oncology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Interventional Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Interventional Oncology Market Growth Rate Analysis
  • 5.4. Global Interventional Oncology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Interventional Oncology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Interventional Oncology Total Addressable Market (TAM)

6. Interventional Oncology Market Segmentation

  • 6.1. Global Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiation Therapy Devices
  • Ablation Devices
  • Embolization Devices
  • 6.2. Global Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ultrasound
  • Computed Tomography Guided
  • Magnetic Resonance-Guided
  • 6.3. Global Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tumor Ablation
  • Tumor Biopsy
  • Vascular Interventions
  • Palliative Care
  • 6.4. Global Interventional Oncology Market, Segmentation By Application Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • 6.5. Global Interventional Oncology Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Research And Academic Institutions
  • 6.6. Global Interventional Oncology Market, Sub-Segmentation Of Radiation Therapy Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Linear Accelerators
  • Proton Therapy Systems
  • Brachytherapy Devices
  • 6.7. Global Interventional Oncology Market, Sub-Segmentation Of Ablation Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiofrequency Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Irreversible Electroporation Systems
  • 6.8. Global Interventional Oncology Market, Sub-Segmentation Of Embolization Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microspheres
  • Coil Embolization Devices
  • Liquid Embolic Agents
  • Embolic Protection Devices

7. Interventional Oncology Market Regional And Country Analysis

  • 7.1. Global Interventional Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Interventional Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Interventional Oncology Market

  • 8.1. Asia-Pacific Interventional Oncology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Interventional Oncology Market

  • 9.1. China Interventional Oncology Market Overview
  • 9.2. China Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Interventional Oncology Market

  • 10.1. India Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Interventional Oncology Market

  • 11.1. Japan Interventional Oncology Market Overview
  • 11.2. Japan Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Interventional Oncology Market

  • 12.1. Australia Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Interventional Oncology Market

  • 13.1. Indonesia Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Interventional Oncology Market

  • 14.1. South Korea Interventional Oncology Market Overview
  • 14.2. South Korea Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Interventional Oncology Market

  • 15.1. Western Europe Interventional Oncology Market Overview
  • 15.2. Western Europe Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Interventional Oncology Market

  • 16.1. UK Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Interventional Oncology Market

  • 17.1. Germany Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Interventional Oncology Market

  • 18.1. France Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Interventional Oncology Market

  • 19.1. Italy Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Interventional Oncology Market

  • 20.1. Spain Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Interventional Oncology Market

  • 21.1. Eastern Europe Interventional Oncology Market Overview
  • 21.2. Eastern Europe Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Interventional Oncology Market

  • 22.1. Russia Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Interventional Oncology Market

  • 23.1. North America Interventional Oncology Market Overview
  • 23.2. North America Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Interventional Oncology Market

  • 24.1. USA Interventional Oncology Market Overview
  • 24.2. USA Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Interventional Oncology Market

  • 25.1. Canada Interventional Oncology Market Overview
  • 25.2. Canada Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Interventional Oncology Market

  • 26.1. South America Interventional Oncology Market Overview
  • 26.2. South America Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Interventional Oncology Market

  • 27.1. Brazil Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Interventional Oncology Market

  • 28.1. Middle East Interventional Oncology Market Overview
  • 28.2. Middle East Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Interventional Oncology Market

  • 29.1. Africa Interventional Oncology Market Overview
  • 29.2. Africa Interventional Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Interventional Oncology Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Interventional Oncology Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Interventional Oncology Market Competitive Landscape And Company Profiles

  • 30.1. Interventional Oncology Market Competitive Landscape
  • 30.2. Interventional Oncology Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Interventional Oncology Market Other Major And Innovative Companies

  • 31.1. Terumo Corporation
  • 31.2. Hologic Inc.
  • 31.3. Teleflex Incorporated
  • 31.4. Lantheus Holdings Inc.
  • 31.5. Penumbra Inc.
  • 31.6. Merit Medical Systems Inc.
  • 31.7. Guerbet S.A
  • 31.8. Asahi Intecc Co. Ltd.
  • 31.9. AngioDynamics Inc.
  • 31.10. Sirtex Medical Limited.
  • 31.11. Delcath Systems Inc.
  • 31.12. ABK Biomedical Inc.
  • 31.13. Profound Medical Inc.
  • 31.14. IceCure Medical Ltd.
  • 31.15. Minimax Medical Holding Group

32. Global Interventional Oncology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Interventional Oncology Market

34. Recent Developments In The Interventional Oncology Market

35. Interventional Oncology Market High Potential Countries, Segments and Strategies

  • 35.1 Interventional Oncology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Interventional Oncology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Interventional Oncology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer